Hunter Test
Roar Ambition Ltd (premium tier)
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Dietary supplement (not FDA-evaluated for efficacy)
Reference only. Not medical advice.
What can go wrong
D-aspartic acid at 3 g matches the positive untrained-men study but is null-to-negative in trained men. Vitamin D3 5,000 IU is above the adult tolerable upper intake if stacked with other sources. Promotion is heavily affiliate-driven.
This is something to take to a clinician. The Atlas can tell you what is known about hunter test in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Hunter Test is the premium product in Roar Ambition's 'Hunter' line (sibling to TestoFuel and Prime Male). Its fully-disclosed 6-capsule label reports high doses: D-aspartic acid 3,000 mg, vitamin D3 5,000 IU, ashwagandha 300 mg, Asian ginseng 300 mg, indole-3-carbinol 200 mg, zinc 30 mg, boron 10 mg, and vitamin K2 150 mcg. Roar Ambition markets premium positioning and label transparency; Ēnel does not endorse the efficacy claims.
Roar Ambition's high-dose 'premium' booster at a premium price.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
What people get wrong
Often saidHigh doses guarantee results
ActuallyHigher doses of weakly-evidenced ingredients do not create efficacy. The finished Hunter Test formula has no published trial.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Premium-priced DTC sales to Roar Ambition.
At a glance
- Maker
- Roar Ambition Ltd
- D-aspartic acid
- 3,000 mg
- Vitamin D3
- 5,000 IU
- Serving
- 6 capsules/day
- Price
- ~$80/bottle
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Hunter Test. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.